Consensus Becton, Dickinson and Company

Stocks

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 00:00:03 14/10/2026 +04			5-day change	1st Jan Change
187.37 ^USD	-0.80%		+3.92%	-3.45%

10-08	Health Care Up on Defensive Bias -- Health Care Roundup	DJ
10-07	BD (Becton, Dickinson And Company) Announces Positive Nine-Month Results From The Iliac Cohort Of The AGILITY Investigational Device Exemption Trial Evaluating The Revello? Vascular Covered Stent	CI

Evolution of the Average Target: Becton, Dickinson and Company

Evolution of the Target Price: Becton, Dickinson and Company

Changes in Analyst Recommendations: Becton, Dickinson and Company

0bd634716302bfffebcdc3df9f.WWxzFoL6u4iGWEz8OUs3OmMHQhIFjfbb5cPAbiAiFvQ.AAcWUNaAwuv3DnrMQHlBYCtdOlZdxZ7rh_G3A2dKd5ENBkpi06n_z_wSeA~d46dfcde00a9d10300f5b8ee634f9b92

Analysts' recommendations: Becton, Dickinson and Company

10-07	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $210 From $180	MT
10-07	Barclays Initiates Coverage on Becton, Dickinson and Company With Underweight Rating, $165 Price Target	MT
10-02	Argus Research Adjusts Becton, Dickinson and Company Price Target to $210 From $180, Maintains Buy Rating	MT
08-31	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT
08-13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
08-13	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
08-12	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
08-07	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
08-07	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
08-07	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
08-07	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
08-07	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
08-07	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
08-05	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $182 From $163	MT
07-28	UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target	MT
07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-09	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
07-06	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190	MT
06-12	BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177	MT
05-27	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
05-08	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
05-07	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
05-07	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
05-04	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BECTON, DICKINSON AND COMPANY					+2.75%
	ABBOTT LABORATORIES					+18.56%
	MEDTRONIC PLC					+13.61%
	STRYKER CORPORATION					+28.31%
	ESSILORLUXOTTICA					+52.61%
	CENCORA, INC.					+13.8%
	HOYA CORPORATION					+20.53%
	IDEXX LABORATORIES, INC.					+33.86%
	DEXCOM, INC.					+12%
	MEDLINE INC.					+24.23%
	Average					+22.03%
	Weighted average by Cap.					+22.07%